Kiniksa Pharmaceuticals International, plc
KNSA
$19.31
$0.663.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.89M | -12.69M | -3.91M | -17.70M | 25.24M |
| Total Depreciation and Amortization | 400.00K | 399.00K | 430.00K | 466.00K | 540.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.72M | 4.45M | 18.56M | 12.65M | -17.49M |
| Change in Net Operating Assets | 20.54M | 5.60M | -9.91M | 8.58M | -3.96M |
| Cash from Operations | 18.77M | -2.24M | 5.17M | 3.99M | 4.33M |
| Capital Expenditure | -193.00K | 0.00 | 0.00 | -84.00K | -56.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 25.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.49M | -6.35M | -46.82M | 25.61M | -14.84M |
| Cash from Investing | 65.29M | -6.35M | -46.80M | 25.52M | -14.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.72M | 9.40M | 1.14M | 3.99M | 957.00K |
| Repurchase of Common Stock | -578.00K | -2.71M | -1.31M | -381.00K | -262.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.14M | 6.69M | -178.00K | 3.61M | 695.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.21M | -1.90M | -41.81M | 33.12M | -9.87M |
